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Purpose: The aims of this study were to determine the
factors affecting the outcome of patent ductus arteriosus
ligation in very low birth weight infants (VLBWI) and
demonstrate the safety of PDA ligation in VLBWI performed
in the neonatal intensive care unit (NICU). Materials and
Methods: From October 1994 to July 2006, medical records
of 94 VLBWI weighing < 1,500 g who underwent PDA
ligation in the NICU of Samsung Medical Center were
reviewed retrospectively. Factors affecting the final outcome
of PDA ligation were evaluated by dividing the infants into
3 groups according to mortality and major morbidities as
follows: mortality group (Mo), major morbidity group (Mb),
and no major morbidity group (NM). Results: In the Mo
group, birth weight was significantly lower and the preopera-
tive mean FiO2 and mean dopamine dose were significantly
higher than those in the other 2 groups. There was no
significant difference in gestational age, incidence of RDS,
number of courses of indomethacin, surgery-related factors,
including weight and age at surgery, perioperative vital signs,
and complications after surgery between the 3 groups. During
surgery in the NICU, there were no significant hemodynamic
instability or serious acute complications. Conclusion: The
factors affecting the outcome of surgery in VLBWI are not
the factors related to surgery but the preoperative conditions
related to the underlying prematurity. PDA ligation of
VLBWI performed in the NICU is safe without serious
complications.
Key Words: Patent ductus arteriosus, ligation, neonatal
intensive care unit, very low birth weight infants
INTRODUCTION
PDA is an important problem in preterm infants,
particularly in VLBWI, and is with significantly
associated with high mortality and morbidity,
including bronchopulmonary dysplasia (BPD),
retinopathy of prematurity (ROP), intraventricular
hemorrhage (IVH), and necrotizing enterocolitis
(NEC).
1-7 PDA can be closed either pharmacologi-
cally with indomethacin or surgically. Indeed,
surgical PDA ligation is usually considered after
failure or contraindication of indomethacin
treatment. Several studies have examined the
appropriate time for surgery, influence of
indomethacin, or adequate indications of surgery
in VLBWI. Some studies reported that early
surgical ligation was beneficial compared to
delayed surgery,
4-6,8,9 and other studies have
reported that more courses of indomethacin before
surgical ligation leads to increased morbidity.
6
However, the optimal timing of PDA ligation in
VLBWI remains controversial, and the factors
affecting the ultimate outcome of surgical closure
are unclear.
Another issue of PDA ligation is the location of
the operation. Because of the risks of transferring
unstable babies to an operating room, surgery in
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the NICU bedside is preferred nowadays.
3,7,10,11
PDA ligation in our NICU was first performed
in 1994. This study evaluated the final outcomes
after PDA ligation, such as morbidity, mortality
and factors that might affect the final outcomes of
surgical ligation and demonstrated the safety of
PDA ligation in the NICU.
MATERIALS AND METHODS
Medical records of 94 VLBWI weighing < 1,500
g with PDA who underwent PDA ligation in the
NICU at Samsung Medical Center (SMC) from
October 1994 to July 2006 were reviewed retro-
spectively. In all cases, PDA was confirmed using
2-dimensional echocardiography.
Mortality and morbidity of the infants were
investigated as the ultimate outcomes. Factors
affecting the final outcome were evaluated by
dividing the patients into 3 groups according
to mortality and major morbidities as follows:
(1) the Mo group, infants who expired; (2) Mb
group, those who had 1 or more morbidities,
including moderate to severe BPD, high grade of
ROP, high stage of NEC, and high grade of
IVH; and (3) NM group, those who survived
without major morbidity.
Factors that might affect the final outcomes
were identified by comparing the following
variables between the 3 groups: gestational age,
birth weight, age and weight at surgery, incidence
of RDS, number of courses of indomethacin,
perioperative ventilatory parameters and vital
signs, the use of dopamine, surgery-related com-
plications, duration of ventilation and total days
of oxygen support, and the length of hospital stay.
The ventilatory parameters, including the fraction
of inspired oxygen (FiO2) and mean airway pressure
(MAP) as well as the vital signs, including body
temperature, heart rate, and blood pressure, were
assessed before the onset of surgery and 48 hours
after surgery. Major morbidity was defined as
follows: high grade IVH was grade III; high
stage ROP requiring laser therapy; high grade
NEC was grade III; and moderate to severe
BPD was defined as an oxygen dependency at the
corrected age of 36 weeks according to Walsh et
al.
12
Surgical ligation of PDA in the NICU
The surgical team performed the ligation on
critically ill VLBWI with PDA in the NICU. The
experienced surgical team consisted of pediatric
cardiothoracic surgeons, circulating nurses, scrub
nurses, and a pediatric anesthesiologist. Infants
were moved on their overhead radiant warmer
next to their incubators for surgery and were then
checked for continuous monitoring, including
oxygen saturation, heart rate, and blood pressure.
General anesthesia was induced with fentanyl,
and vecuronium provided curarisation. Infants
were positioned in the right lateral decubitus
position and all ligations were performed through
a left thoracotomy via the 4th or 5th intercostal
space intrapleurally. The parietal pleura on the
aorta and PDA was divided, and the ductus
arteriosus was mobilized and ligated using a 1/0
silk suture with 3 knots or a hemoclip.
Neonatologists remained in continuous atten-
dance of the infant from before surgery until its
completion and adequate postoperative stabiliza-
tion. Anyone entering the NICU were required to
wear proper operating attire, including caps,
surgical gowns, shoes, and masks.
Statistical analysis
Statistical analysis was performed by SPSS
using ANOVA, chi-square test, and Fisher’s exact
test. In addition, SAS was performed using
Spearman correlation analysis with Bonferroni
correction, one-way ANOVA, and Kruskal-Wallis
Test. A p value < 0.05 was considered significant.
RESULTS
Outcome of surgery
The postoperative mortality was 1% at 7 days,
13% at 30 days, and 20% at hospital discharge.
One (1%) infant who underwent surgery died 3
days later due to underlying sepsis before
surgery. There were 20 (21%) final deaths, and the
median postnatal age of death was 70 ± 69 days
(ranging from 9 to 235 days). The causes of final
death were as follows: sepsis (n = 13, 65%), severePDA Ligation in VLBWI
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BPD and Cor pulmonale (n = 3, 15%), high-grade
intracranial hemorrhage (n = 2, 10%), high stage
NEC (n = 1, 5%), and ARF (n= 1, 5%). No mortality
was directly related to the surgery.
Forty-three (46%) infants had major morbidity.
Among those who had more than 1 major
morbidity, BPD occurred in 29 (67%) infants.
Thirty-six (84%) infants had high stage ROP, 18
(19%) had high grade IVH, and 4 (4%) had high
grade NEC. Thirty-one (33%) infants survived to
discharge without any major morbidity.
There was no significant difference in the
duration of ventilation between the 3 groups (Mb,
50 ± 12 days vs Mo, 50 ± 22 days vs NM, 36 ± 18
days). However, in the Mb group, the number of
oxygen support days (Mb, 82 ± 16 days; Mo, 73 ±
70 days; and NM, 59 ± 22 days), and hospital days
(Mb, 100 ± 23 days; Mo, 73 ± 70 days; and NM, 62
± 19 days) was significantly longer than in the Mo
and NM groups (p < 0.05).
Factors affecting the outcome (Table 1)
In the Mo group, birth weight was significantly
lower than in the NM and Mb groups (p < 0.05).
However, there was no significant difference in
gestational age, weight and age at surgery,
incidence of RDS, and number of courses of
indomethacin between the 3 groups.
Indications of surgery (Table 2)
Table 2 shows the indications of surgery. There
was no significant difference in the indications for
surgery between the 3 groups.
Perioperative conditions (Table 3)
Table 2 shows the ventilatory parameters and
vital signs before the onset of surgery and 48
hours after surgery. The preoperative mean FiO2
Table 1. Demographic Details
NM group
(n = 31)
Mo group
(n = 20)
Mb group
(n = 43)
Total
(n = 94)
Gestational age (week
+day) 27
+0 ± 2
+3 26
+2 ± 2
+5 26
+0 ± 1
+6 26
+3 ± 2
+1
Birth weight (gm) 954 ± 234 788 ± 228*, 847 ± 196 869 ± 223
RDS 28 (90%) 20 (100%) 42 (98%) 90 (96%)
Age at surgery (days) 15 ± 9 12 ± 10 16 ± 9 15 ± 9
Weight at surgery (gm) 987 ± 290 816 ± 250 946 ± 308 931 ± 295
N. of courses of indomethacin 1.7 ± 0.9 1.3 ± 0.9 1.6 ± 0.8 1.5 ± 0.8
Inborn/outborn (n) 23/8 (35%) 18/2 (11%) 40/3 (8%) 94/13 (14%)
RDS, respiratory distress syndrome; N, number; NM, no major mobidity group; Mo, mortality group; Mb, major mobidity group.
*p < 0.05 vs N group, p < 0.05 vs Mo group.
Table 2. Indications for Surgery
Indications of surgery NM group
(n = 31)
Mo group
(n = 20)
Mb group
(n = 43)
Total
(n = 94)
Indocin associated problem* 21 (68%) 11 (55%) 25 (58%) 57 (67%)
ARF 0 (0%) 2 (10%) 0 (0%) 2 (2%)
Medical or surgical GI problem 6 (19%) 3 (15%) 7 (16%) 16 (17%)
Pulmonary hemorrhage or
Thrombocytopenia
4 (13%) 4 (20%) 11 (26%) 19 (20%)
ARF, acute renal failure; GI, gastrointestinal; NM, no major mobidity group; Mo, mortality group; Mb, major mobidity group.
*Indocin failure defined as persistent PDA after the use of two or more courses of indomethacin or acute renal failure related
to indomethacin.
Suspicious NEC (n = 9), spontaneous bowel perforation (n = 6) and previous duodenal atresia surgery (n = 1).Ga Yeun Lee, et al.
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and mean dopamine dose were significantly
higher in the Mo group than in the Mb and NM
groups (p < 0.05). In the Mo group, the mean FiO2
and mean dopamine dose 48 hours after surgery
were still higher than in the NM group (p< 0.05).
Other variables, including MAP, body temperature,
blood pressure, heart rate, and number of infants
using dopamine, were similar in the 3 groups.
Surgery-related complications
Table 4 shows surgery-related complications.
There was no significant difference in the occur-
rence of surgical complications between the 3
groups. There was minimal or no bleeding within
24 hours postoperatively requiring a blood transfu-
sion, no hypothermia, and no dislodgement of the
E-tube and catheter. There were no other surgical
complications, such as postoperative wound
infections, NEC, phrenic nerve palsy, vocal cord
paresis and chylothorax.
All patients received follow-up echocardio-
graphy after surgery and there was no residual
PDA in any patient.
Table 3. Perioperative Conditions
NM group
(n = 31)
Mo group
(n = 20)
Mb group
(n = 43)
p value
Before surgery
MAP (mmHg) 7.8 ± 2.8 9.2 ± 4.3 9.0 ± 4.5 NS
FiO2 0.3 ± 0.1 0.5 ± 0.3*, 0.3 ± 0.1 0.028
Blood pressure (mmHg) 35 ± 7 37 ± 9 37 ± 7 NS
Body temperature (°C) 36.6 ± 0.3 36.6 ± 0.4 36.6 ± 0.4 NS
Pulse rate ( /min) 154 ± 15 156 ± 9 157 ± 11 NS
Use of dopamine (n) 5 (16%) 8 (40%) 12 (28%) NS
Dose of dopamine (mcg/kg/min) 1 ± 2 5 ± 8*, 2 ± 4 0.011
48 hr after surgery
MAP (mmHg) 6.7 ± 4.2 9.4 ± 5.4 9.0 ± 4.7 NS
FiO2 0.3 ± 0.1 0.5 ± 0.3*, 0.4 ± 0.2 0.035
Blood pressure (mmHg) 40 ± 7 40 ± 9 40 ± 5 NS
Body temperature (°C) 36.6 ± 0.2 36.5 ± 0.2 36.6 ± 0.3 NS
Pulse rate ( /min) 145 ± 8 147 ± 7 148 ± 9 NS
Use of dopamine (n) 5 (16%) 8 (40%) 13 (30%) NS
Dose of dopamine (mcg/kg/min) 1 ± 2 5 ± 8*, 3 ± 5 0.038
MAP, mean airway pressure; FiO2, fraction of inspired oxygen; NM, no major mobidity group; Mo, mortality group; Mb, major
mobidity group; NS, not significant.
*p < 0.05 vs NM group, p < 0.05 vs Mb group.
Table 4. Surgery-Related Complications
NM group
(n = 31)
Mo group
(n = 20)
Mb group
(n = 43)
Total
(n = 94)
p value
Atelectasis* 13 (24%) 9 (17%) 25 (46%) 47 (87%) NS
Hyperglycemia ( 300 mg/dL) 2 (4%) 1 (2%) 1 (2%) 4 (8%) NS
Feeding intolerance 3 (6%) 0 (0%) 0 (0%) 6 (6%) NS
Pneumothorax 1 (2%) 1 (2%) 1 (2%) 3 (6%) NS
NM, no major mobidity group; Mo, mortality group; Mb, major mobidity group; NS, not significant.
*Reversible atelectasis recovered within 24 hours postoperatively.PDA Ligation in VLBWI
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DISCUSSION
The present results showed low mortality rates
of 1% at 7 days, 13% at 30 days, and 20% at
hospital discharge after surgical PDA ligation. No
mortality was related directly to the procedure
but was attributed to the underlying prematurity.
This mortality rate is similar to that reported in
previous studies,
6,13 which showed that PDA
ligation performed in the NICU is safe and
feasible even in VLBWI.
Because indomethacin inhibits the synthesis of
all prostaglandins, a wide variety of adverse
effects can be expected, including NEC, intestinal
perforation, renal failure, and thrombocytopenia.
VLBWI are more susceptible to these complica-
tions, and 40% are unlikely to respond to
indomethacin therapy.
1,5,7,9,14,15 Palder et al.
5
reported a higher failure rate of indomethacin in
infants < 750 g in weight, suggesting that direct
ligation might be the preferable treatment. Little
et al.
15 revealed that infants weighing < 1,000 g
were less likely to respond to indomethacin than
infants weighing > 1,000 g. Rudd et al.
16 reported
that 87% of infants weighing < 1000g at birth were
initially closed with indomethacin but 47% of
these reopened. Therefore, surgical ligation might
be considered in VLBWI who have either a lower
probability of PDA closure with indomethacin or
a higher risk of developing complications from
indomethacin. However, indications, optimal time
of surgery, and factors affecting the outcomes of
surgical ligation in VLBWI are unclear.
As discussed above, in order to determine the
factors affecting the final outcomes after surgery,
the infants were divided into 3 groups according
to their mortality and major morbidities, and
several variables that were expected to affect the
outcome of PDA ligation were compared. In the
3 groups, there was no significant difference in
gestational age, weight and age at surgery,
number of courses of indomethacin, perioperative
MAP and vital sign, including blood pressure,
pulse rate, and body temperature. This suggests
that these factors can lead to a similar final
outcome after surgery. However, in the mortality
group, birth weight was significantly lower than
in the no morbidity and morbidity group but the
preoperative and postoperative mean FiO2 and
mean dopamine dose was significantly higher
than in the NM group. This means that the
severity of the preoperative conditions related to
underlying prematurity is the most important
factor that affect the final outcomes of PDA
ligation in VLBWI.
Overall, there was a significant difference in the
total oxygen time and hospital days between the
3 groups because in the mortality group, some
patients expired due to their underlying severe
preoperative condition. In this condition, oxygen
support time and hospital days were shorter.
Moreover, in the Mb group, infants had major
morbidities that required prolonged additive
therapy, particularly, BPD, which required
prolonged oxygenation support.
It was recently suggested that an early surgical
ligation of PDA was preferable for VLBWI. Jaillard
et al.
8 reported that the ventilatory requirement
was lower and nutritional outcome was better
when early surgical closure was performed. Lee et
al.
6 demonstrated delayed surgery and increasing
respiratory morbidity if 2 or more courses of
indomethacin had been given. But, in the present
study, no significant difference was observed in
the surgery time and the courses of indomethacin,
and there was no significant difference in the
surgery time between the 3 groups. Therefore,
surgery time may not affect the outcome of PDA
ligation.
It was concluded that PDA ligation can be con-
sidered at any time in VLBWI when indomethacin
either failed to close or was contraindicated
because the factors related to surgery, including
surgery time, number of courses of indomethacin,
preoperative vital signs, and postoperative com-
plications, may not significantly affect the out-
comes.
As the design of our study is retrospective, it
does not allow us to rule out the comorbidity of
indomethacin. The prospective study in the future
will be necessary to clarify the above notion.
There are several reports demonstrating that the
surgical ligation of PDA in VLBWI operated in the
NICU is safe, with a risk for infection similar to
the operation room,
11 also reducing the risks
inherent in patient transport.
3 The aim of ligation
in the NICU is to eliminate the risks encountered
while transferring the most fragile infants to theGa Yeun Lee, et al.
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operating room. The transferal of a sick neonate
may be associated with significant morbidity,
such as unstable hemodynamics, hypothermia,
disruption of the vascular lines, and dislodgement
of the endotracheal tube. Furthermore, there may
be delays because an operating room may be
unavailable when required. In contrast, the
advantages of performing surgery at the NICU
include elimination of the aforementioned risks
involved in transferring the patient and, throughout
surgery, the infant can be cared for by the same
nurses and doctors who are familiar with the
infant, vascular access, and ventilator requirements.
Furthermore, vital treatments, such as inhaled
nitric oxide, which may have to be discontinued
while transferring the neonate to the operating
room, can be continued at the NICU without
disruption.
3,7,10,11 Although an anesthetic machine
and gaseous anesthetic agents are generally
unavailable in the NICU, the narcotics relaxant
technique using intravenous fentanyl used at
ligation at NICU is an effective anesthesia for
neontates.
5 Shew et al.
17 reported that the whole-
body protein breakdown, protein turnover and
skeletal muscle protein breakdown rates improved
significantly after surgery with fentanyl in low
birth weight infants who had a minimal metabolic
reservoir and previously experienced a loss of
protein while enduring the physiologic stress of a
PDA.
The disadvantage of performing surgery in the
NICU includes limited lighting and accessibility,
and beds in the ICU are not adjustable for surgery.
In addition, the degree of asepsis achieved in the
NICU is less effective than in an operating room
due to higher levels of traffic in the ICU and
lower airflow per minute in the ICU. However,
the incidence of complications in several previous
reports was quite low despite the marked
prematurity of the patients,
1,4,11,18 and were not
serious complications related to surgery.
This study provides useful data on the
outcomes of VLBWI undergoing PDA ligation in
the NICU. The retrospective design represents a
limitation and warrants future prospective design.
In conclusion, the factors affecting the outcome
of surgery in VLBWI are the preoperative
conditions related to the underlying prematurity,
including birth weight, preoperative FiO2, and
mean dopamine dose. In addition, PDA ligation
performed in the NICU is a safe and feasible and
is not associated with significant complications,
even in VLBWI. Therefore, surgical ligation of
PDA can be considered at any time for the
treatment of VLBWI who have either a lower
probability of PDA closure with indomethacin or
an increased risk of developing complications
from indomethacin.
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